AXSM - Axsome Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$255.81
DETAILS
HIGH:
$302.00
LOW:
$200.00
MEDIAN:
$259.50
CONSENSUS:
$255.81
UPSIDE:
8.41%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 92.6% |
| EBIT Margin | -27.7% |
| EBITDA Margin | -26.3% |
| Operating Margin | -26.5% |
| Pretax Margin | -28.8% |
| Cont. Ops Margin | -28.7% |
| Net Margin | -28.7% |
| Bottom Line Margin | -28.7% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 1.55 |
| Quick Ratio | 1.48 |
| Solvency Ratio | -0.289 |
| Cash Ratio | 0.85 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-49.60
Peers avg: 23.4
|
| PEG Ratio | 1.29 |
| Forward PEG | 1.29 |
| Price/Book | 102.90 |
| Price/Sales | 14.23 |
| Price/FCF | -96.78 |
| Price/Op Cash Flow | -97.27 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.3498 |
| Debt/Equity | 2.7328 |
| Debt/Capital | 0.7321 |
| Long-Term Debt/Capital | 0.6148 |
| Financial Leverage | 7.81 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 2.75 |
| Operating Cash Flow Ratio | -0.247 |
| Operating Cash Flow/Sales | -14.6% |
| Free Cash Flow/Operating Cash Flow | 100.5% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -2.11 |
| Interest Coverage | -25.8098 |
| Short-Term Operating Cash Flow Coverage | -1.28 |
| Operating Cash Flow Coverage | -0.39 |
| Capital Expenditure Coverage | -194.59 |
| Dividend + Capital Expenditure Coverage | -194.59 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 12.83 |
| EPS | -3.682 |
| Debt/Share | 4.9822 |
| Cash/Share | 6.49 |
| Book Value/Share | 1.77 |
| Tangible BV/Share | 0.72 |
| Equity/Share | 1.77 |
| Operating Cash Flow/Share | -1.878 |
| Capital Expenditure/Share | 0.010 |
| FCF/Share | -1.887 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.997 |
| Earnings Before Tax/EBIT | 1.085 |
| Price/Fair Value | 102.90 |
| Debt/Market Cap | 0.0235 |
| Effective Tax Rate | 0.3% |
| Enterprise Value Multiple | -53.57 |